The use of immunofluorescence to evaluate the efficacy of malarial chemoprophylaxis.
338 subjects occupationally exposed to high levels of malaria transmission were randomly assigned to three groups. Group A received one tablet of mefloquine (250 mg) and one tablet of sulfadoxine-pyrimethamine once a week, group B received two tablets of sulfadoxine-pyrimethamine once a week and group C received one tablet of sulfadoxine-pyrimethamine (each containing sulfadoxine 500 mg and pyrimethamine 25 mg) twice a week. Blood films for malaria parasites and filter paper strips for serological study were taken before and at 5 and 12 months after the chemoprophylaxis. The advantages and inherent limitation of the slide positivity rate and the usefulness of geometric mean reciprocal titre for the assessment of the efficacy of the chemoprophylaxis were discussed.
Myint Lwin
Department of Medical Research, Military Hospital, Rangoon, Burma.
Kyaw Win
Ye Htut
Ye Thwe
Tin Thein Lwin
Khin Win
D000293:Adolescent; D000328:Adult; D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis*; D004359:Drug Therapy, Combination; D005455:Fluorescent Antibody Technique; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D008297:Male; D015767:Mefloquine; D010963:Plasmodium falciparum / Q000276:immunology*; D011739:Pyrimethamine / Q000008:administration & dosage; D011804:Quinolines / Q000008:administration & dosage; D011897:Random Allocation; D013413:Sulfadoxine / Q000008:administration & dosage
D000913:Antibodies, Protozoan; D011804:Quinolines; D013413:Sulfadoxine; D015767:Mefloquine; D011739:Pyrimethamine